We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPTX
101
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$34.6M 0.24%
520,625
– –
BRK.B icon
102
Berkshire Hathaway Class B
BRK.B
$1.07T
$34.2M 0.23%
125,182
+12,092
+11% +$3.4M
MMM icon
103
3M
MMM
$91.9B
$34M 0.23%
232,023
+5,385
+2% +$872K
BIO icon
104
Bio-Rad Laboratories Class A
BIO
$8.47B
$33.4M 0.23%
44,843
-12,415
-22% -$9.3M
TGT icon
105
Target
TGT
$63.7B
$33.2M 0.23%
145,204
+24,967
+21% +$6.25M
PNC icon
106
PNC Financial Services
PNC
$99.6B
$33M 0.22%
168,591
+59,983
+55% +$11.3M
BLD
107
DELISTED
TopBuild
BLD
$32.7M 0.22%
159,500
-94,249
-37% -$19.8M
SNPS icon
108
Synopsys
SNPS
$74.5B
$32.5M 0.22%
108,562
-2,419
-2% -$734K
MDLZ icon
109
Mondelez International
MDLZ
$77.9B
$32.4M 0.22%
557,504
+408,532
+274% +$25.4M
PLD icon
110
Prologis
PLD
$137B
$32.3M 0.22%
257,402
-8,075
-3% -$1.05M
BPMC
111
DELISTED
Blueprint Medicines
BPMC
$32.2M 0.22%
312,950
– –
INFO
112
DELISTED
IHS Markit Ltd. Common Shares
INFO
$32.1M 0.22%
275,609
-920
-0.3% -$109K
CCI icon
113
Crown Castle
CCI
$32.4B
$31.8M 0.22%
183,525
+84,919
+86% +$16.4M
LLY icon
114
Eli Lilly
LLY
$1.07T
$31.8M 0.22%
137,547
+15,756
+13% +$3.89M
SAIL
115
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$31.5M 0.21%
735,725
-2,508
-0.3% -$119K
PPD
116
DELISTED
PPD, Inc. Common Stock
PPD
$31.3M 0.21%
669,870
+272,899
+69% +$12.6M
BNS icon
117
Scotiabank
BNS
$106B
$31.1M 0.21%
506,216
+41,978
+9% +$2.63M
BNTX icon
118
BioNTech
BNTX
$23B
$30.9M 0.21%
113,197
+9,100
+9% +$2.89M
AMBA icon
119
Ambarella
AMBA
$2.99B
$30.6M 0.21%
196,587
-661
-0.3% -$76K
OTIS icon
120
Otis Worldwide
OTIS
$27.9B
$30.6M 0.21%
371,665
+89,827
+32% +$7.9M
RF icon
121
Regions Financial
RF
$26.2B
$30.1M 0.2%
1,414,013
+129,578
+10% +$2.58M
ADP icon
122
Automatic Data Processing
ADP
$102B
$29.2M 0.2%
146,264
+20,486
+16% +$4.22M
NOW icon
123
ServiceNow
NOW
$109B
$28.7M 0.19%
230,290
+130,735
+131% +$15.8M
CVS icon
124
CVS Health
CVS
$137B
$28.5M 0.19%
335,298
+7,166
+2% +$600K
ARVN icon
125
Arvinas
ARVN
$530M
$28.4M 0.19%
345,594
+94,991
+38% +$8.4M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.